Danske Bank downgraded Zealand Pharma to Sell from Hold with an DKK 800 price target.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ZLDPF:
- ZLDPF Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- Zealand Pharma appoints Eric Cox as CCO
- Zealand Pharma participates in a conference call with Cantor Fitzgerald
- Zealand Pharma price target raised to DKK 1,080 from DKK 815 at Berenberg
- Zealand sees body weight reductions up to mean 8.6% with high dose petrelintide